These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 28131048

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Adipose-derived protein omentin prevents neointimal formation after arterial injury.
    Uemura Y, Shibata R, Kanemura N, Ohashi K, Kambara T, Hiramatsu-Ito M, Enomoto T, Yuasa D, Joki Y, Matsuo K, Ito M, Hayakawa S, Ogawa H, Murohara T, Ouchi N.
    FASEB J; 2015 Jan; 29(1):141-51. PubMed ID: 25300621
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Epac1 Deficiency Attenuated Vascular Smooth Muscle Cell Migration and Neointimal Formation.
    Kato Y, Yokoyama U, Yanai C, Ishige R, Kurotaki D, Umemura M, Fujita T, Kubota T, Okumura S, Sata M, Tamura T, Ishikawa Y.
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2617-25. PubMed ID: 26427796
    [Abstract] [Full Text] [Related]

  • 11. Adipose-derived factor CTRP9 attenuates vascular smooth muscle cell proliferation and neointimal formation.
    Uemura Y, Shibata R, Ohashi K, Enomoto T, Kambara T, Yamamoto T, Ogura Y, Yuasa D, Joki Y, Matsuo K, Miyabe M, Kataoka Y, Murohara T, Ouchi N.
    FASEB J; 2013 Jan; 27(1):25-33. PubMed ID: 22972916
    [Abstract] [Full Text] [Related]

  • 12. Novel role of copper transport protein antioxidant-1 in neointimal formation after vascular injury.
    Kohno T, Urao N, Ashino T, Sudhahar V, McKinney RD, Hamakubo T, Iwanari H, Ushio-Fukai M, Fukai T.
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):805-13. PubMed ID: 23349186
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Thrombospondin-4 ablation reduces macrophage recruitment in adipose tissue and neointima and suppresses injury-induced restenosis in mice.
    Lv L, Liang W, Ye M, Zhang J, Zhang H, Xue G, Zhang L.
    Atherosclerosis; 2016 Apr; 247():70-7. PubMed ID: 26868511
    [Abstract] [Full Text] [Related]

  • 15. miR-22 Is a Novel Mediator of Vascular Smooth Muscle Cell Phenotypic Modulation and Neointima Formation.
    Yang F, Chen Q, He S, Yang M, Maguire EM, An W, Afzal TA, Luong LA, Zhang L, Xiao Q.
    Circulation; 2018 Apr 24; 137(17):1824-1841. PubMed ID: 29246895
    [Abstract] [Full Text] [Related]

  • 16. Intermedin reduces neointima formation by regulating vascular smooth muscle cell phenotype via cAMP/PKA pathway.
    Zhu Q, Ni XQ, Lu WW, Zhang JS, Ren JL, Wu D, Chen Y, Zhang LS, Yu YR, Tang CS, Qi YF.
    Atherosclerosis; 2017 Nov 24; 266():212-222. PubMed ID: 29053988
    [Abstract] [Full Text] [Related]

  • 17. C1q/TNF-related protein-1 functions to protect against acute ischemic injury in the heart.
    Yuasa D, Ohashi K, Shibata R, Mizutani N, Kataoka Y, Kambara T, Uemura Y, Matsuo K, Kanemura N, Hayakawa S, Hiramatsu-Ito M, Ito M, Ogawa H, Murate T, Murohara T, Ouchi N.
    FASEB J; 2016 Mar 24; 30(3):1065-75. PubMed ID: 26578687
    [Abstract] [Full Text] [Related]

  • 18. Zinc finger protein 191 deficiency attenuates vascular smooth muscle cell proliferation, migration, and intimal hyperplasia after endovascular arterial injury.
    Lv L, Zhang J, Wang P, Meng Q, Liang W, Zhang L.
    J Vasc Surg; 2014 Feb 24; 59(2):500-9. PubMed ID: 23755975
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.